Drawing for PLECOID

USPTO serial 79306239

PLECOID

Reviewed by CopyMark Law Group

Reg. 6733742Status 700Registered
Filing date
Status date
Registration date
May 24, 2022
Examiner
OSGOOD, KRYSTINA E
Law office
PUBLICATION AND ISSUE SECTION

What this means

Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six. Calendar Section 8 between years five and six, and consider trademark monitoring.

Status 700: Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six.

Need help with PLECOID?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Thomas D. Bratschun

Thomas D. Bratschun Adsero IP8210 Southpark TerraceLittleton, CO 80120UNITED STATES

Goods and services

ClassDescriptionStatusFirst use
001Chemicals for use in science, scientific research and for laboratory use; analytical and diagnostic reagents for in vitro use for scientific and research purposesACTIVE—
005Pharmaceuticals for the treatment of viral infections; pharmaceuticals for the treatment of cardiovascular disorders and conditions; pharmaceuticals for the treatment of neurological diseases and disorders; pharmaceuticals for the treatment of respiratory disorders and conditions; pharmaceuticals for the treatment of fungal diseases and disorders; pharmaceuticals for the treatment of liver disease; pharmaceuticals for the treatment of HIV/AIDS and hepatitis; pharmaceuticals for the treatment of inflammatory diseases and disorders; pharmaceuticals for the treatment of cancer; pharmaceutical preparations for immunotherapy, including t cell therapyACTIVE—
044Providing health and medical information about medical disorders and their diagnosis, prevention and treatment; counselling and charitable services for patients, namely, providing medical information and assistance with respect to obtaining prescription medications; medical consultation, namely, providing advice to healthcare professionals regarding medical disorders and their diagnosis, prevention and treatment; providing medical information; providing medical information regarding treatment, prevention, and diagnosis of medical conditions; medical information and advisory services relating to pharmaceuticals, diseases and medical conditions and treatment, including such services provided on-line from a computer network or the InternetACTIVE—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Oct 2, 2022FINOFINAL DECISION TRANSACTION PROCESSED BY IB—
Sep 14, 2022FICSFINAL DISPOSITION NOTICE SENT TO IB—
Sep 14, 2022FIMPFINAL DISPOSITION PROCESSED—
Aug 24, 2022FICRFINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB—
May 24, 2022NRCCNOTICE OF REGISTRATION CONFIRMATION EMAILED—
May 24, 2022R.PRREGISTERED-PRINCIPAL REGISTERYour trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive.
Mar 8, 2022NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED—
Mar 8, 2022PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Mar 7, 2022GPNXNOTIFICATION PROCESSED BY IB—
Feb 16, 2022OPNSNOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB—
Feb 16, 2022OP2RNOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB—
Feb 16, 2022NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED—
Feb 2, 2022CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Jan 21, 2022TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Jan 20, 2022CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Jan 20, 2022TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Aug 8, 2021RFNTREFUSAL PROCESSED BY IB—
Jul 22, 2021RFCSNON-FINAL ACTION MAILED - REFUSAL SENT TO IB—
Jul 22, 2021RFRRREFUSAL PROCESSED BY MPU—
Jul 14, 2021RFCRNON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW—
Jul 13, 2021CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Jul 13, 2021DOCKASSIGNED TO EXAMINER—
May 21, 2021ADCHCHANGE OF NAME/ADDRESS REC'D FROM IB—
Mar 16, 2021MAFRAPPLICATION FILING RECEIPT MAILED—
Mar 12, 2021NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Mar 11, 2021REPRSN ASSIGNED FOR SECT 66A APPL FROM IB—

Frequently asked questions

Related guidance